Viewing Study NCT03422068


Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2025-12-25 @ 3:02 PM
Study NCT ID: NCT03422068
Status: COMPLETED
Last Update Posted: 2025-11-28
First Post: 2018-01-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-03-16
Start Date Type: ACTUAL
Primary Completion Date: 2019-07-01
Primary Completion Date Type: ACTUAL
Completion Date: 2019-07-10
Completion Date Type: ACTUAL
First Submit Date: 2018-01-22
First Submit QC Date: None
Study First Post Date: 2018-02-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-11-14
Results First Submit QC Date: None
Results First Post Date: 2025-11-28
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-14
Last Update Post Date: 2025-11-28
Last Update Post Date Type: ESTIMATED